CAC (gated) Algorithm vs ElucidVivo A.3
AI Verdict
Choose CAC (gated) Algorithm if…
Choose CAC (gated) Algorithm if your primary need is automated, rapid quantification of coronary artery calcium from existing non-contrast ECG-gated cardiac CT scans. This tool is ideal for initial cardiovascular risk assessment and opportunistic detection of coronary artery disease, streamlining the identification of patients who may benefit from further evaluation based on calcium burden.
View CAC (gated) Algorithm →Choose ElucidVivo A.3 if…
Choose ElucidVivo A.3 if you require in-depth, quantitative analysis of arterial plaque composition and stability from CT angiography to refine atherosclerosis patient stratification and optimize treatment strategies. This system is particularly suited for cases where understanding specific plaque characteristics, such as lipid-rich necrotic core and fractional flow reserve, is crucial for advanced clinical decision-making.
View ElucidVivo A.3 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CAC (gated) Algorithm | ElucidVivo A.3 |
|---|---|---|
| Deployment | Unknown | Cloud and on-premise secure deployment. |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CAC (gated) AlgorithmTool A, BunkerHill Health's CAC (gated) Algorithm, emphasizes seamless integration into physicians' standard workflows and pre-populates structured reports, directly streamlining tasks and reducing manual effort for radiologists. While Tool B also integrates with PACS/EMR, the mention of Elucid Analysts performing segmentation as a service for Elucid PlaqueIQ might introduce an additional step or reduce direct physician control, making Tool A's workflow integration appear more direct and efficient for the end-user physician.
Clinical Value
ElucidVivo A.3Tool B, ElucidVivo A.3, offers a more advanced and comprehensive assessment of atherosclerosis by providing quantitative analysis of arterial plaque composition and stability, including the quantification of Lipid-Rich Necrotic Core (LRNC) and derivation of fractional flow reserve (FFRct). This detailed plaque characterization is validated against ground-truth histology and has demonstrated a 40% improvement in predictive accuracy for major adverse neurologic events, offering deeper clinical insights than Tool A's focus on coronary artery calcium quantification alone.
Pricing & Value
TieBoth tools require direct contact with the vendor for pricing information, indicating a lack of public pricing transparency. However, both have recently secured significant reimbursement pathways, with Tool A gaining a CMS reimbursement pathway and Tool B achieving broad reimbursement from United Healthcare and a new Category I CPT code, making both highly valuable for adoption by healthcare providers.
Enterprise Readiness
CAC (gated) AlgorithmTool A explicitly states HIPAA compliance, BAA availability, and cloud deployment, along with SOC 2 Type II and ISO/IEC 27001:2022 certifications. It is also part of the broader Carebricks platform, which is designed for AI-powered workflows and seamless EHR integration. While Tool B offers cloud and on-premise deployment and states 'HIPAA-aligned' data protection, Tool A's comprehensive and explicit certifications and platform approach provide a stronger indication of enterprise readiness.
Innovation
ElucidVivo A.3Tool B demonstrates greater innovation through its histology-validated quantitative analysis of arterial plaque composition and stability, including the ability to quantify specific plaque components like LRNC and derive FFRct from CT angiography. Its exploration of 'Virtual Transcriptomics' further highlights a more profound advancement in understanding disease pathology and risk compared to Tool A's focus on automated coronary artery calcium quantification.
Support & Docs
TieBased on the provided structured facts and web search results, neither Tool A nor Tool B offers explicit details regarding dedicated customer support channels, service level agreements, or comprehensive technical documentation. While Tool A mentions a 'Workflow Library' and 'Case Studies,' these do not provide sufficient information to distinguish its support and documentation from Tool B, for which no specific details were found.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CAC (gated) Algorithm | ElucidVivo A.3 |
|---|---|---|
| Tool Name | CAC (gated) Algorithm | ElucidVivo A.3 |
| Company | BunkerHill Health | Elucid Bioimaging |
| Primary Focus | Automatically detects and quantifies coronary artery calcium from non-contrast ECG-gated cardiac CT scans, aiding physicians in assessing coronary artery health. | Quantitative analysis of arterial plaque composition and stability from CT angiography, assists in atherosclerosis patient stratification and optimizes treatment decisions. |
| Analyzed Imaging Modality | non-contrast ECG-gated cardiac CT scans | CT angiography |
| Key Output/Analysis Type | Automatic detection and quantification of coronary artery calcium (CAC), calcium segmentation and quantification, pre-populates structured reports. | Quantitative analysis of arterial plaque (Lipid-Rich Necrotic Core, matrix, calcifications), 3D visualization of highlighted vessels, fractional flow reserve (FFRct) derivation. |
Videos
Demos, reviews, and walkthroughs featuring CAC (gated) Algorithm and ElucidVivo A.3.